🇺🇸 FDA

Drug profile · INN

albendazole

ALBENDAZOLE

approved
US status
approved
Patents linked
3
News articles
0

Quick answer

albendazole (ALBENDAZOLE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN albendazole
Brand ALBENDAZOLE
Route ORAL
Formulation TABLET

Related patents

Search patents →

  1. US 10220022

    Compositions and methods employing Wolbachia FtsZ as a target for Albendazole sulfone

    Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10028936

    Compositions and methods employing Wolbachia FtsZ as a target for Albendazole sulfone

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9439889

    Methods employing wolbachia FtsZ as a target for albendazole sulfone

    Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is albendazole?

albendazole (ALBENDAZOLE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for albendazole?

ALBENDAZOLE is a marketed brand name for albendazole. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of albendazole?

albendazole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.